Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:BACKNASDAQ:BGLCNASDAQ:BTTXNASDAQ:NIVF On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeBACKIMAC$0.03-16.1%$0.25$0.03▼$4.13$63K1.67437,989 shs2,270 shsBGLCBioNexus Gene Lab$2.79-2.1%$2.94$2.01▼$8.40$5.01M5.41268,944 shs32,976 shsBTTXBetter Therapeutics$0.00$0.00$0.00▼$0.03$10K1.1515,606 shs358 shsNIVFNewGenIvf Group$0.28-4.4%$0.85$0.26▼$65.60$1.45M0.18903,182 shs2.63 million shs2025 Gold Forecast: A Perfect Storm for DemandUnlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceBACKIMAC-9.75%-13.22%-42.61%-94.36%-99.01%BGLCBioNexus Gene Lab-3.06%-1.38%+20.56%-29.63%-54.02%BTTXBetter Therapeutics0.00%0.00%-33.33%+100.00%-98.46%NIVFNewGenIvf Group-7.79%-20.04%-55.05%-94.45%-99.18%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationBACKIMACN/AN/AN/AN/AN/AN/AN/AN/ABGLCBioNexus Gene Lab0.268 of 5 stars0.02.00.00.03.10.00.0BTTXBetter TherapeuticsN/AN/AN/AN/AN/AN/AN/AN/ANIVFNewGenIvf Group1.9088 of 5 stars0.04.00.00.03.03.30.6Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceBACKIMAC 0.00N/AN/AN/ABGLCBioNexus Gene Lab 0.00N/AN/AN/ABTTXBetter Therapeutics 0.00N/AN/AN/ANIVFNewGenIvf Group 0.00N/AN/AN/ACompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookBACKIMAC$72.05K0.87N/AN/A($0.66) per share-0.05BGLCBioNexus Gene Lab$9.51M0.53N/AN/A$0.55 per share5.07BTTXBetter TherapeuticsN/AN/AN/AN/AN/AN/ANIVFNewGenIvf Group$5.14M0.28$0.09 per share3.11$2.19 per share0.13Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateBACKIMAC-$9.42MN/A0.00∞N/AN/AN/A-325.44%5/5/2025 (Estimated)BGLCBioNexus Gene Lab-$2.63MN/A0.00∞N/A-10.17%-9.93%-8.43%5/21/2025 (Estimated)BTTXBetter Therapeutics-$39.76MN/A0.00∞N/AN/AN/AN/A5/1/2025 (Estimated)NIVFNewGenIvf Group$130KN/A0.00∞N/AN/AN/AN/AN/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthBACKIMACN/AN/AN/AN/AN/ABGLCBioNexus Gene LabN/AN/AN/AN/AN/ABTTXBetter TherapeuticsN/AN/AN/AN/AN/ANIVFNewGenIvf GroupN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioBACKIMACN/A0.080.08BGLCBioNexus Gene LabN/A4.973.99BTTXBetter TherapeuticsN/AN/AN/ANIVFNewGenIvf GroupN/AN/AN/ACompare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipBACKIMAC5.84%BGLCBioNexus Gene Lab18.85%BTTXBetter Therapeutics34.00%NIVFNewGenIvf Group66.24%Insider OwnershipCompanyInsider OwnershipBACKIMAC12.26%BGLCBioNexus Gene Lab0.70%BTTXBetter Therapeutics51.40%NIVFNewGenIvf Group31.80%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableBACKIMAC1802.07 million1.82 millionNot OptionableBGLCBioNexus Gene Lab301.80 million17.61 millionNot OptionableBTTXBetter Therapeutics4049.86 million24.23 millionOptionableNIVFNewGenIvf GroupN/A5.27 million346,000N/ABGLC, NIVF, BACK, and BTTX HeadlinesRecent News About These CompaniesNewGenIVF Announces Reverse Stock SplitMay 1 at 10:25 AM | globenewswire.comNewGenIvf Group reports FY24 EPS (64c) vs. $3.53 last yearApril 23, 2025 | markets.businessinsider.comNewGenIvf Group Limited Files Annual Report for Fiscal Year 2024, Highlights Strong Financial PositionApril 22, 2025 | quiverquant.comNewGen Filed 2024 Annual Report on Form 20-FApril 22, 2025 | globenewswire.comBRIEF-Newgenivf Group-On April 15, Approved Reverse Stock Split Of All Of Co’S Issued And Unissued SharesApril 16, 2025 | sg.finance.yahoo.comNewGenIvf Group secures $5.2M in funding to drive international expansionApril 3, 2025 | markets.businessinsider.comNewGen Secures Strategic Funding to Drive International Expansion and Corporate GrowthApril 3, 2025 | globenewswire.comNewGenIvf Group Secures Additional Debt Financing to Bolster Market PositionApril 3, 2025 | tipranks.comNewGenIvf Group Ends Reverse Merger Agreement With European Wellness Investment HoldingsApril 2, 2025 | nasdaq.comNewGenIvf announces termination of merger transaction with European WellnessApril 1, 2025 | markets.businessinsider.comNewGenIVF Announces Termination of Proposed Reverse Merger Transaction with European WellnessMarch 31, 2025 | globenewswire.comNewGenIvf Group files to sell 9.275M Class A ordinary shares for holdersMarch 7, 2025 | markets.businessinsider.comNewGenIvf Group Limited Provides Update on Proposed Reverse Merger with EWIHL and Acquisition of MicroSort TechnologyMarch 7, 2025 | quiverquant.comNewGenIvf Provides Update on Proposed Reverse Merger with European Wellness Holdings and Completion of Strategic Acquisition of MicroSort Reproductive TechnologyMarch 7, 2025 | globenewswire.comNewGenIvf, BOBCARE enter collab to expand fertility services in KyrgyzstanMarch 3, 2025 | markets.businessinsider.comNewGenIvf Group Limited Partners with BOBCARE to Expand Fertility Services in KyrgyzstanMarch 3, 2025 | quiverquant.comNewGen and BOBCARE Announce Strategic Collaboration to Expand Fertility Services in KyrgyzstanMarch 3, 2025 | globenewswire.comNewGenIvf regains compliance with Nasdaq rule, announces listing transferFebruary 28, 2025 | markets.businessinsider.comNewGenIvf Group Limited Regains Compliance with Nasdaq Listing Requirements and Transfers to Nasdaq Capital MarketFebruary 28, 2025 | quiverquant.comNewGen Regains Compliance with Nasdaq Minimum Bid Price Requirement and Announces Listing Transfer to the Nasdaq Capital MarketFebruary 28, 2025 | globenewswire.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeTop HeadlinesView All HeadlinesAre Tariffs Threatening Disney’s Comeback Story?By Jea Yu | April 9, 2025View Are Tariffs Threatening Disney’s Comeback Story?5 Reasons the S&P 500 Could Rebound Strongly in 2025By Thomas Hughes | April 3, 2025View 5 Reasons the S&P 500 Could Rebound Strongly in 2025These 3 Stocks Have Huge Last 12 Months Shareholder YieldsBy Leo Miller | April 18, 2025View These 3 Stocks Have Huge Last 12 Months Shareholder YieldsWho Led Buybacks to End 2024? Hint: It Wasn’t Big TechBy Leo Miller | April 8, 2025View Who Led Buybacks to End 2024? Hint: It Wasn’t Big TechTesla's Band-Aid Has Been Ripped Off: Rally Mode EngagedBy Sam Quirke | April 30, 2025View Tesla's Band-Aid Has Been Ripped Off: Rally Mode EngagedBGLC, NIVF, BACK, and BTTX Company DescriptionsIMAC NASDAQ:BACK$0.03 -0.01 (-16.07%) As of 02:22 PM EasternIMAC Holdings, Inc. owns and manages innovative medical advancements and care regeneration centers, and backspace clinics in the United States. The company's outpatient medical clinics provide regenerative, orthopedic, and minimally invasive procedures and therapies to patients with sports injuries, ligament and tendon damage, and other related soft tissue conditions, as well as back, knee, and joint pains. It also provides medical treatments, regenerative, spinal decompression, chiropractic manipulation, and physical medicine and therapy. IMAC Holdings, Inc. was founded in 2000 and is headquartered in Franklin, Tennessee.BioNexus Gene Lab NASDAQ:BGLC$2.79 -0.06 (-2.11%) Closing price 03:58 PM EasternExtended Trading$2.78 -0.01 (-0.36%) As of 06:18 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.BioNexus Gene Lab Corp., through its subsidiary, sells chemical raw material products in Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. The company offers chemical raw material products, which include Polyester Resin SHCP 268, a thixotropic, quick-curing unsaturated polyester resin suitable as a general-purpose resin; Polyester Resin 9509, a general-purpose material used in production of marine boats and water slides; and Polyester Resin 2802 used as a component in the pultrusion process by certain manufacturers. Its products are used to produce handrails, bench tops, automotive and aero parts, and paneling for hospital, laboratory, industrial clean rooms, and covers for various instruments used in manufacturing. The company also involves in developing and providing non-invasive liquid biopsy tests for the early detection of biomarkers to detect potential risk of diseases. It markets its products through its website, warehouse, marketing personnel, and suppliers. The company was incorporated in 2017 and is based in Kuala Lumpur, Malaysia.Better Therapeutics NASDAQ:BTTX$0.0002 0.00 (0.00%) As of 04/30/2025 03:16 PM EasternBetter Therapeutics, Inc., a prescription digital therapeutics company, develops a form of cognitive behavioral therapy to address the causes of cardiometabolic diseases. The company's lead product candidate is BT-001, an investigational PDT platform to treat type 2 diabetes. It also develops software-based prescription digital therapeutics platform candidates for treating diabetes, heart disease, and other cardiometabolic conditions. In addition, the company's clinical development candidates are intended to treat cardiometabolic diseases, including type 2 diabetes, hypertension, hyperlipidemia, non-alcoholic fatty liver disease, non-alcoholic steatohepatitis, and chronic kidney disease. Its product pipeline also includes BT-002, which intends glycemic control for hypertension; BT-003 to reduce LDL cholesterol in patients with hyperlipidemia; and BT-004, which intends to explore the impact of treatment on liver health in patients with non-alcoholic steatohepatitis/non-alcoholic fatty liver disease. The company was founded in 2015 and is headquartered in San Francisco, California.NewGenIvf Group NASDAQ:NIVF$0.28 -0.01 (-4.41%) Closing price 03:59 PM EasternExtended Trading$0.28 +0.00 (+1.45%) As of 07:58 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.NewGenIVF Group Ltd. operates as an assisted reproductive services provider. It focuses on providing fertility treatments to fulfil the dreams of building families. The firm offers in-vitro fertilization treatment service, comprising traditional IVF and egg donation, and surrogacy and ancillary caring services. The company is headquartered in Bangkok, Thailand. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Microsoft Crushes Earnings, What’s Next for MSFT Stock? McDonald’s Insiders Sell Shares! Investors Should Do the Opposite Qualcomm's Earnings: 2 Reasons to Buy, 1 to Stay Away Broadcom: Buy, Hold, Sell? AI & Acquistions Paint Strong Picture Hershey Hits the Sweet Spot for Defensive Investors A Bull Case for Adobe Stock Remains Today AMD Stock Signals Strong Buy Ahead of Earnings BigBear.ai: A Short-Squeeze Is Possible, a Sharp Drop Is Likely Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
